BDMD
Baird Medical Investment Holdings Ltd.
NASDAQ · Healthcare · Medical - Devices · CN
$0.18
−27.20%Year over year
Reported trailing growth
- Revenue
- -23.1%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +154.1%
- Operating cash flow
- +177.6%
Forward estimates
Based on analyst estimates
- Revenue
- -28.1%
- EBITDA
- +136.0%
- EPS
- +114.6%
Three-year CAGR
- Revenue
- -13.7%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +84.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026